Change of migrated PBMC subtypes after MB and LPSMB treatment.
- Isabella Werner (495362)
- Fengwei Guo (495363)
- Nicolai V. Bogert (495364)
- Ulrich A. Stock (495365)
- Patrick Meybohm (20539)
- Anton Moritz (37179)
- Andres Beiras-Fernandez (495366)
Publication date
December 2013
DOIAbstract
<p>(A1–E1) MB treatment of HuMEC-1 previous to transmigration assay. (A2–E2) LPSMB treatment of HuMEC-1 previous to transmigration assay. (A1, A2) Migrated granulocytes, (B1, B2) Migrated B-lymphocytes. (C1,C2) Migrated T-lymphocytes. (D1, D2) Migrated CD14++ monocytes. (E1,E2) Migrated CD14++CD16++ monocytes. (each experiment n = 3) (§ p<0.05 vs. control; # p<0.05 vs. LPS, *p<0.05).</p
Add to ORKG